[HTML][HTML] Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep …

L Zhang, Y Jiang, Z Jin, W Jiang, B Zhang, C Wang… - Cancer imaging, 2022 - Springer
Background Transcatheter arterial chemoembolization (TACE) is the mainstay of therapy for
intermediate-stage hepatocellular carcinoma (HCC); yet its efficacy varies between patients …

[HTML][HTML] Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep …

L Zhang, Y Jiang, Z Jin, W Jiang… - Cancer …, 2022 - cancerimagingjournal.biomedcentral …
Transcatheter arterial chemoembolization (TACE) is the mainstay of therapy for intermediate-
stage hepatocellular carcinoma (HCC); yet its efficacy varies between patients with the same …

[HTML][HTML] Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep …

L Zhang, Y Jiang, Z Jin, W Jiang, B Zhang… - Cancer …, 2022 - ncbi.nlm.nih.gov
Background Transcatheter arterial chemoembolization (TACE) is the mainstay of therapy for
intermediate-stage hepatocellular carcinoma (HCC); yet its efficacy varies between patients …

Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based …

L Zhang, Y Jiang, Z Jin, W Jiang… - … imaging: the official …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Transcatheter arterial chemoembolization (TACE) is the mainstay of therapy for
intermediate-stage hepatocellular carcinoma (HCC); yet its efficacy varies between patients …

Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based …

L Zhang, Y Jiang, Z Jin, W Jiang, B Zhang… - Cancer Imaging: the …, 2022 - europepmc.org
Background Transcatheter arterial chemoembolization (TACE) is the mainstay of therapy for
intermediate-stage hepatocellular carcinoma (HCC); yet its efficacy varies between patients …

Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based …

L Zhang, Y Jiang, Z Jin, W Jiang, B Zhang… - Cancer …, 2022 - search.proquest.com
Background Transcatheter arterial chemoembolization (TACE) is the mainstay of therapy for
intermediate-stage hepatocellular carcinoma (HCC); yet its efficacy varies between patients …